Gastric cancer is the high mortality rate cancers globally, and the current survival rate is 30%
even with the use of combination therapies. Recently, mounting evidence indicates the …

Aim: This study aimed to accurately identification of potential miRNAs for gastric cancer (GC)
diagnosis at the early stages of the disease. Methods: We used GSE106817 data with 2,566 …

Gastric cancer is one of the most common malignancies in China and exhibits a poor
prognosis. The most significant challenge for gastric cancer treatment is the absence of early …

Gastric cancer is one of the leading causes of cancer mortality in the world. Aberrant
expression of microRNAs (miRNAs) is the hallmark of this disease. MiRNAs are …

Gastric cancer has a high incidence and mortality rate worldwide; however, the use of
biomarkers for its clinical diagnosis remains limited. The microRNAs (miRNAs) are …

Carcinoma of the stomach is one of the most prevalent cancer types in the world. Although
the incidence of gastric cancer is declining, the outcomes of gastric cancer patients remain …

Gastric cancer (GC) remains a major cause of morbidity and mortality worldwide and there is
therefore a clear need to search for more sensitive early diagnostic biomarkers. We …

Gastric cancer (GC) is the second leading cause of cancer-related death in the world. The
optimal treatment regimens for GC depend on tumor stage, histopathological subtype, and …

Early detection of gastric cancer (GC) is crucial to improve the therapeutic effect and prolong
the survival of patients. MicroRNAs (miRNAs) are a group of small non-protein-coding RNAs …

Gastric cancer (GC) is one of the leading types of malignancy worldwide, particularly in
Asian populations. Although the exact molecular mechanism of GC development remains …